HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lipopolysaccharide results in a marked decrease in hepatocyte nuclear factor 4 alpha in rat liver.

Abstract
The acute-phase response can result in decreased liver-specific functions and death as a result of liver failure. We show here that lipopolysaccharide (LPS), an endotoxin that induces the acute-phase response, results in a marked decrease in the major isoforms of the transcription factor, hepatocyte nuclear factor 4 alpha (HNF-4 alpha), in livers of rats. HNF-4 alpha is a nuclear receptor that is critical for the expression of several liver-specific genes. This decrease in HNF-4 alpha is primarily the result of a posttranscriptional mechanism, because mRNA levels are normal, and there are no major changes in the splicing patterns. This decrease was of functional significance, because expression of a gene that is highly dependent on HNF-4 alpha, HNF-1 alpha, was reduced. Interleukin-1 beta (IL-1 beta) is a cytokine whose levels are increased in vivo in response to LPS. IL-1 beta resulted in a decrease in HNF-4 alpha levels in HepG2 cells. This IL-1 beta-induced decrease was likely caused by degradation via the proteasome, because it was prevented by the addition of the proteasome inhibitor, MG132. We conclude that the decrease in HNF-4 alpha that occurs in vivo after the administration of LPS may be the result of IL-1 beta-induced degradation, and likely contributes to the liver insufficiency that occurs. IL-1 beta antagonists or proteasome inhibitors might increase HNF-4 alpha protein levels in the acute-phase response, which could result in increased liver function and survival.
AuthorsB Wang, S R Cai, C Gao, F M Sladek, K P Ponder
JournalHepatology (Baltimore, Md.) (Hepatology) Vol. 34 Issue 5 Pg. 979-89 (Nov 2001) ISSN: 0270-9139 [Print] United States
PMID11679969 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • DNA-Binding Proteins
  • Hepatocyte Nuclear Factor 4
  • Interleukin-1
  • Lipopolysaccharides
  • Phosphoproteins
  • Protein Isoforms
  • RNA, Messenger
  • Transcription Factors
  • DNA
Topics
  • Animals
  • DNA (metabolism)
  • DNA-Binding Proteins
  • Hepatocyte Nuclear Factor 4
  • Immunohistochemistry
  • Interleukin-1 (pharmacology)
  • Intracellular Membranes (metabolism)
  • Lipopolysaccharides (pharmacology)
  • Liver (metabolism)
  • Male
  • Phosphoproteins (antagonists & inhibitors, genetics, metabolism)
  • Protein Isoforms (antagonists & inhibitors)
  • RNA, Messenger (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Repetitive Sequences, Nucleic Acid
  • Tissue Distribution
  • Transcription Factors (antagonists & inhibitors, genetics, metabolism)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: